Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Abstract

Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Electrochemical (radio)-halodesilylation of aromatic silanes

“…In another respect, radioiodine-related radiopharmaceuticals have always been important in molecular imaging, radionuclide therapy, and drug development, and several molecules have already been approved by the FDA in the last few decades. 11 Thus, many efforts have been made for radiolabeling methodology development to meet the demands of preclinical and clinical research. 12 Nevertheless, these methods still suffer from similar problems to those of traditional halogenation methods.…”